Jing Qin

机构：Zhejiang Cancer Hospital, Zhejiang Academy of Medical Sciences, Hangzhou Cancer Hospital, Air Force Medical University · ORCID：0000-0002-4477-3334

发表论文 84 篇 · 总被引 1195 次 · h-index 15

代表论文

• circROBO1 promotes prostate cancer growth and enzalutamide resistance via accelerating glycolysis (2023 · Journal of Cancer · 被引 54)
• Long noncoding RNA DGCR5 involves in tumorigenesis of esophageal squamous cell carcinoma via SRSF1-mediated alternative splicing of Mcl-1 (2021 · Cell Death and Disease · 被引 48)
• Shikonin suppresses small cell lung cancer growth via inducing ATF3-mediated ferroptosis to promote ROS accumulation (2023 · Chemico-Biological Interactions · 被引 40)
• Brain radiotherapy combined with camrelizumab and platinum-doublet chemotherapy for previously untreated advanced non-small-cell lung cancer with brain metastases (C-Brain): a multicentre, single-arm, phase 2 trial (2025 · The Lancet Oncology · 被引 32)
• Empagliflozin modulates CD4 + T‐cell differentiation via metabolic reprogramming in immune thrombocytopenia (2022 · British Journal of Haematology · 被引 30)
• Comparison of the efficacy and safety of first-line treatments based on clinicopathological characteristics for patients with advanced epidermal growth factor receptor mutated non-small-cell lung cancer: A systematic review and network meta-analysis (2022 · Critical Reviews in Oncology/Hematology · 被引 15)